Table 1.
Characteristic | No. of patients (%) |
---|---|
Sex | |
Male | 20 (47.6) |
Female | 22 (52.4) |
Median age (range, yr) | 63 (30-81) |
Treatment setting of imatinib | |
Neoadjuvant | 8 (19.0) |
Adjuvant | 11 (26.2) |
Palliative | 23 (54.8) |
Imatinib dose at the time of skin rash (mg) | |
800 | 1 (2.4) |
600 | 1 (2.4) |
400 | 38 (90.5) |
300 | 2 (4.8) |
Grade of skin rash | |
3 | 40 (95.2) |
4 | 2 (4.8) |